Figure 2.

PPARγ protein was assessed with Western blotting. Lane 1, 10 µmol/L rosiglitazone group; lane 2, 3 µmol/L rosiglitazone group; lane 3, control group.

PPARγ protein was assessed with Western blotting. Lane 1, 10 µmol/L rosiglitazone group; lane 2, 3 µmol/L rosiglitazone group; lane 3, control group.